LONDON – Stem cell therapy specialist Reneuron plc has raised £33 million (US$50.7 million), including a placing to bring in £23.35 million and a £7.8 million grant from the Welsh Government, in a financing package that will enable the company to build its own manufacturing facility and take three lead programs through to proof of efficacy in Phase II. Read More
LONDON – A full range of about 5,000 mutant mice, each with a single known gene inactivated, will be openly available to researchers within the next few years for further study of abnormal features that will shed light on numerous human diseases. Read More
AB Science SA received a €5.9 million (US$7.8 million) funding boost for its Phase III development program of masitinib in Alzheimer's disease. Read More
LONDON – If the claim is true, then drug delivery has never been so exciting, or more profound. "We are rethinking psychiatry," said Richard Pops, CEO of Alkermes plc, giving an update on the portfolio at the company's R&D day. Read More
An emergency committee convened by World Health Organization (WHO) director-general, Margaret Chan, concluded that at this point, the Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) does not warrant being declared a public health emergency of international concern. Read More
• Mesoblast Ltd., of Melbourne, Australia, received about $4.3 million under the Australian government's Innovation Australia Research and Development Tax Incentive Program. The funds will be used to advance development of Mesoblast's mesenchymal precursor cell technology platform and product pipeline. Read More
